Effect of Mulligan on Sub-acromial Space in Patients With Shoulder Impingement Syndrome
NCT ID: NCT05439525
Last Updated: 2022-06-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2022-07-05
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
the patient will receive Shoulder complex mobilization with movement three time a week for two weeks
mulligan technique
The patient will be in sitting and the therapist stands on the contralateral side of pain, stabilizing the scapula posteriorly with one hand. The head of the humerus is translated posteriorly and laterally with the other hand, along the plane of the glenoid fossa. While the glide is sustained, the patient actively elevates their arm through the plane of abduction or scaption (elevation). Apply 6-10 repetitions in a set, with 3-5 sets in a treatment session the perform mobilization on acromioclavicular and sternoclavicular joint
conventional therapy
1. Flexibility exercises: enhance flexibility of the glenohumeral Posterior capsule, pectoralis muscle, and upper thoracic spine.
2. Strengthen the rotator cuff and scapular stabilizers.
3. Improve upper-quarter postural awareness
Group B
will receive Conventional therapy three times a week for two weeks.
conventional therapy
1. Flexibility exercises: enhance flexibility of the glenohumeral Posterior capsule, pectoralis muscle, and upper thoracic spine.
2. Strengthen the rotator cuff and scapular stabilizers.
3. Improve upper-quarter postural awareness
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mulligan technique
The patient will be in sitting and the therapist stands on the contralateral side of pain, stabilizing the scapula posteriorly with one hand. The head of the humerus is translated posteriorly and laterally with the other hand, along the plane of the glenoid fossa. While the glide is sustained, the patient actively elevates their arm through the plane of abduction or scaption (elevation). Apply 6-10 repetitions in a set, with 3-5 sets in a treatment session the perform mobilization on acromioclavicular and sternoclavicular joint
conventional therapy
1. Flexibility exercises: enhance flexibility of the glenohumeral Posterior capsule, pectoralis muscle, and upper thoracic spine.
2. Strengthen the rotator cuff and scapular stabilizers.
3. Improve upper-quarter postural awareness
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Shoulder pain and two out of four specified objective signs and symptoms:
Positive Neer impingement test. Positive Hawkins-Kennedy impingement test. Painful or limitation of active shoulder elevation (flexion, abduction, scaption).
Pain or limitation with the functional movement patterns of hand-behind-back or hand-behind-head.
Exclusion Criteria
30 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Al Shaymaa Shaaban Abd El Azeim
principle investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deraya university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Noha alaa eldeen Mahmoud
Role: primary
Amal Hassan Mohammed
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.t.Rec/012/003613
Identifier Type: -
Identifier Source: org_study_id